BiotechTube
Home/GenSight Biologics/Jan Eryk Umiastowski
JE

Jan Eryk Umiastowski

Chief Financial Officer

GenSight Biologics

Therapeutic Areas

OphthalmologyNeurodegenerative Diseases

GenSight Biologics Pipeline

DrugIndicationPhase
GS010 (Lenadogene Nolparvovec / Lumevoq)Leber Hereditary Optic Neuropathy (LHON) due to ND4 mutationPhase 3
GS030Retinitis Pigmentosa (RP)Phase 1/2

Leadership Team at GenSight Biologics

LR
Laurence Rodriguez
Chief Executive Officer
MT
Magali Taiel
Chief Medical Officer
SJ
Scott Jeffers
Chief Technical Officer
JS
José-Alain Sahel
Scientific Founder
BR
Botond Roska
Scientific Founder
View full GenSight Biologics profile